Results 271 to 280 of about 766,818 (299)

PD-1 takes control

Nature Immunology, 2023
openaire   +2 more sources

PD-1

1997
A. Neil Barclay, Marion H. Brown, S.K. Alex Law, Andrew J. McKnight, Michael G. Tomlinson, P. Anton van der Merwe   +5 more
openaire   +1 more source

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine, 2021
Miles Andrews, Connie P Duong, Vancheswaran Gopalakrishnan   +2 more
exaly  

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature, 2021
Jiajia Zhang, Zhicheng Ji, Brian J Mog
exaly  

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1

Nature Medicine, 2022
John A Mcculloch, Diwakar Davar, Jonathan H Badger   +2 more
exaly  

PD-1-Antikörper

Der Hautarzt, 2012
openaire   +1 more source

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

Nature Medicine, 2020
David A Braun, Yue Hou, Ziad Bakouny
exaly  

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

Nature Reviews Clinical Oncology, 2016
Celine Boutros, Ahmad A Tarhini, Olivier Lambotte   +2 more
exaly  

PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas

Nature Reviews Clinical Oncology, 2016
Razelle Kurzrock
exaly  

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

Nature, 2018
Alexander C Huang, Bin Wu, Ting Li
exaly